Folinic acid, 5-fluorouracil and etoposide after curative resection for gastric cancer.

Roberto Petrioli, Marianna Sabatino, Franco Roviello, Daniele Marrelli, G Nastri, Stefania Marsili, Pierpaolo Correale, Daniele Pozzessere, Simona Messinese, Antonio Martino, Francesco Tani, G. Marzocca, Marco Lorenzi, Serenella Civitelli, G. Tanzini, Enrico Pinto, Guido FranciniPubMed 2005

Abstract

Our data suggest that ELF adjuvant treatment is a safe and well tolerable combination chemotherapy in patients with resected gastric cancer, but it does not seem to improve prognosis in comparison with historical controls.
BibTeX
@inproceedings{petrioli2005folinic,
  author = {Roberto Petrioli and Marianna Sabatino and Franco Roviello and Daniele Marrelli and G Nastri and Stefania Marsili and Pierpaolo Correale and Daniele Pozzessere and Simona Messinese and Antonio Martino and Francesco Tani and G. Marzocca and Marco Lorenzi and Serenella Civitelli and G. Tanzini and Enrico Pinto and Guido Francini},
  title = {{Folinic acid, 5-fluorouracil and etoposide after curative resection for gastric cancer.}},
  booktitle = {PubMed},
  year = {2005},
}

Loading related content...

Figure